SCOPUS 정보 검색 플랫폼

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 5, 2005, Pages 767-769

Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients

(6) Hashimoto, Kenji a Engberg, Göran b Shimizu, Eiji a Nordin, Conny c Lindström, Leif H d Iyo, Masaomi a

a CHIBA UNIVERSITY (Japan)

b KAROLINSKA INSTITUTE (Sweden)

c LINKÖPING UNIVERSITY HOSPITAL (Sweden)

d UPPSALA UNIVERSITY (Sweden)

Author keywords

Cerebrospinal fluid (CSF); D Serine; L Serine; NMDA receptor; Schizophrenia

Indexed keywords

DEXTRO SERINE; SERINE;

ADULT; AMINO ACID METABOLISM; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; MALE; PROTEIN CEREBROSPINAL FLUID LEVEL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MALE; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SERINE; STEREOISOMERISM;

EID: 21244502642 PISSN: 02785846 EISSN: None Source Type: Journal
DOI: 10.1016/j.pnpbp.2005.04.023 Document Type: Article

Times cited : (246)

References (12)

1
- 0004235298
- 3rd ed. APA Washington, DC
- American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 3rd ed. 1987 APA Washington, DC
- (1987) Diagnostic and Statistical Manual of Mental Disorders
- Psychiatric Association, A.¹

2
- 0034843738
- The emerging role of glutamate in the pathophysiology and treatment of schizophrenia
- D.C. Goff, J.T. Coyle The emerging role of glutamate in the pathophysiology and treatment of schizophrenia Am. J. Psychiatry 158 2001 1367 1377
- (2001) Am. J. Psychiatry , vol.158 , pp. 1367-1377
- Goff, D.C.¹ Coyle, J.T.²

3
- 0030850891
- Free d-aspartate and d-serine in the mammalian brain and periphery
- A. Hashimoto, T. Oka Free d-aspartate and d-serine in the mammalian brain and periphery Prog. Neurobiol. 52 1997 325 353
- (1997) Prog. Neurobiol. , vol.52 , pp. 325-353
- Hashimoto, A.¹ Oka, T.²

4
- 0037977113
- Decreased serum levels of d-serine in patients with schizophrenia: Evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia
- K. Hashimoto, T. Fukushima, E. Shimizu, N. Komatsu, H. Watanabe, N. Shinoda, M. Nakazato, C. Kumakiri, S. Okada, H. Hasegawa, K. Imai, M. Iyo Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia Arch. Gen. Psychiatry 60 2003 572 576
- (2003) Arch. Gen. Psychiatry , vol.60 , pp. 572-576
- Hashimoto, K.¹ Fukushima, T.² Shimizu, E.³ Komatsu, N.⁴ Watanabe, H.⁵ Shinoda, N.⁶ Nakazato, M.⁷ Kumakiri, C.⁸ Okada, S.⁹ Hasegawa, H.¹⁰ Imai, K.¹¹ Iyo, M.¹²

5
- 2442614201
- Glutamate hypothesis of schizophrenia and approach for possible therapeutic drugs
- K. Hashimoto, N. Okamura, E. Shimizu, M. Iyo Glutamate hypothesis of schizophrenia and approach for possible therapeutic drugs Curr. Med. Chem.-CNS Agents 4 2004 147 154
- (2004) Curr. Med. Chem.-CNS Agents , vol.4 , pp. 147-154
- Hashimoto, K.¹ Okamura, N.² Shimizu, E.³ Iyo, M.⁴

6
- 21244442890
- Dysfunction of glia-neuron communication in pathophysiology of schizophrenia
- K. Hashimoto, E. Shimizu, M. Iyo Dysfunction of glia-neuron communication in pathophysiology of schizophrenia Curr. Psychiatry Rev. 1 2005 151 163
- (2005) Curr. Psychiatry Rev. , vol.1 , pp. 151-163
- Hashimoto, K.¹ Shimizu, E.² Iyo, M.³

7
- 0025952455
- Recent advances in the phencyclidine model of schizophrenia
- D.C. Javitt, S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am. J. Psychiatry 148 1991 1301 1308
- (1991) Am. J. Psychiatry , vol.148 , pp. 1301-1308
- Javitt, D.C.¹ Zukin, S.R.²

8
- 0028850552
- Glutamate receptor dysfunction and schizophrenia
- J.W. Olney, N.B. Farber Glutamate receptor dysfunction and schizophrenia Arch. Gen. Psychiatry 52 1995 998 1007
- (1995) Arch. Gen. Psychiatry , vol.52 , pp. 998-1007
- Olney, J.W.¹ Farber, N.B.²

9
- 0033765902
- Novel neurotransmitters and their neuropsychiatric relevance
- S.H. Snyder, C.D. Ferris Novel neurotransmitters and their neuropsychiatric relevance Am. J. Psychiatry 157 2000 1738 1751
- (2000) Am. J. Psychiatry , vol.157 , pp. 1738-1751
- Snyder, S.H.¹ Ferris, C.D.²

10
- 0031979134
- Schizophrenia and glutamatergic transmission
- C.A. Tamminga Schizophrenia and glutamatergic transmission Crit. Rev. Neurobiol. 12 1998 21 36
- (1998) Crit. Rev. Neurobiol. , vol.12 , pp. 21-36
- Tamminga, C.A.¹

11
- 0032532459
- Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia
- G. Tsai, D.P. van Kammen, S. Chen, M.E. Kekky, A. Grier, J.T. Coyle Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia Biol. Psychiatry 44 1998 667 674
- (1998) Biol. Psychiatry , vol.44 , pp. 667-674
- Tsai, G.¹ Van Kammen, D.P.² Chen, S.³ Kekky, M.E.⁴ Grier, A.⁵ Coyle, J.T.⁶

12
- 0027400406
- Abnormal serine-glycine metabolism in the brains of schizophrenics
- R. Waziri, S. Baraiah, A.D. Sherman Abnormal serine-glycine metabolism in the brains of schizophrenics Schizophr. Res. 8 1992 233 243
- (1992) Schizophr. Res. , vol.8 , pp. 233-243
- Waziri, R.¹ Baraiah, S.² Sherman, A.D.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.